{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T04:09:21Z","timestamp":1773806961300,"version":"3.50.1"},"reference-count":252,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T00:00:00Z","timestamp":1364947200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s12035-013-8445-3","type":"journal-article","created":{"date-parts":[[2013,4,2]],"date-time":"2013-04-02T02:12:27Z","timestamp":1364868747000},"page":"556-570","source":"Crossref","is-referenced-by-count":33,"title":["The Senescence Hypothesis of Disease Progression in Alzheimer Disease: an Integrated Matrix of Disease Pathways for FAD and SAD"],"prefix":"10.1007","volume":"48","author":[{"given":"Sally","family":"Hunter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Arendt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Brayne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,3]]},"reference":[{"issue":"9","key":"8445_CR1","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.39.9.1159","volume":"39","author":"JC Morris","year":"1989","unstructured":"Morris JC et al (1989) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39(9):1159\u20131165","journal-title":"Neurology"},{"issue":"4","key":"8445_CR2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS et al (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41(4):479\u2013486","journal-title":"Neurology"},{"key":"8445_CR3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jns.2004.11.036","volume":"229\u2013230","author":"AR Koudinov","year":"2005","unstructured":"Koudinov AR, Koudinova NV (2005) Cholesterol homeostasis failure as a unifying cause of synaptic degeneration. J Neurol Sci 229\u2013230:233\u2013240","journal-title":"J Neurol Sci"},{"issue":"3","key":"8445_CR4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neurobiolaging.2004.09.003","volume":"26","author":"J Poirier","year":"2005","unstructured":"Poirier J (2005) Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease. Neurobiol Aging 26(3):355\u2013361","journal-title":"Neurobiol Aging"},{"issue":"5","key":"8445_CR5","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1194\/jlr.M400486-JLR200","volume":"46","author":"RM Lane","year":"2005","unstructured":"Lane RM, Farlow MR (2005) Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease. J Lipid Res 46(5):949\u2013968","journal-title":"J Lipid Res"},{"issue":"8","key":"8445_CR6","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0006-2952(03)00534-3","volume":"66","author":"A Eckert","year":"2003","unstructured":"Eckert A et al (2003) Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease. Biochem Pharmacol 66(8):1627\u20131634","journal-title":"Biochem Pharmacol"},{"issue":"7\u20138","key":"8445_CR7","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s007020200082","volume":"109","author":"S Hoyer","year":"2002","unstructured":"Hoyer S (2002) The aging brain. Changes in the neuronal insulin\/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). A mini-review. J Neural Transm 109(7\u20138):991\u20131002","journal-title":"J Neural Transm"},{"key":"8445_CR8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-1-4419-8969-7_8","volume":"541","author":"S Hoyer","year":"2004","unstructured":"Hoyer S (2004) Causes and consequences of disturbances of cerebral glucose metabolism in sporadic Alzheimer disease: therapeutic implications. Adv Exp Med Biol 541:135\u2013152","journal-title":"Adv Exp Med Biol"},{"issue":"4558","key":"8445_CR9","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","volume":"217","author":"RT Bartus","year":"1982","unstructured":"Bartus RT et al (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217(4558):408\u2013414","journal-title":"Science"},{"issue":"3","key":"8445_CR10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1474-9726.2007.00275.x","volume":"6","author":"MP Mattson","year":"2007","unstructured":"Mattson MP (2007) Calcium and neurodegeneration. Aging Cell 6(3):337\u2013350","journal-title":"Aging Cell"},{"issue":"4\u20135","key":"8445_CR11","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.neuint.2007.10.002","volume":"52","author":"L Bojarski","year":"2008","unstructured":"Bojarski L, Herms J, Kuznicki J (2008) Calcium dysregulation in Alzheimer's disease. Neurochem Int 52(4\u20135):621\u2013633","journal-title":"Neurochem Int"},{"issue":"2\u20133","key":"8445_CR12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pneurobio.2003.09.007","volume":"71","author":"T Arendt","year":"2003","unstructured":"Arendt T (2003) Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity. Prog Neurobiol 71(2\u20133):83\u2013248","journal-title":"Prog Neurobiol"},{"issue":"12","key":"8445_CR13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrneurol.2009.175","volume":"5","author":"M Fotuhi","year":"2009","unstructured":"Fotuhi M, Hachinski V, Whitehouse PJ (2009) Changing perspectives regarding late-life dementia. Nat Rev Neurol 5(12):649\u2013658","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"8445_CR14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1755-5949.2009.00117.x","volume":"16","author":"S Hunter","year":"2010","unstructured":"Hunter S, Friedland RP, Brayne C (2010) Time for a change in the research paradigm for Alzheimer's disease: the value of a chaotic matrix modeling approach. CNS Neurosci Ther 16(4):254\u2013262","journal-title":"CNS Neurosci Ther"},{"issue":"2","key":"8445_CR15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/alzrt108","volume":"4","author":"S Hunter","year":"2012","unstructured":"Hunter S, Brayne C (2012) Relationships between the amyloid precursor protein and its various proteolytic fragments and neuronal systems. Alzheimers Res Ther 4(2):10","journal-title":"Alzheimers Res Ther"},{"issue":"50","key":"8445_CR16","doi-asserted-by":"crossref","first-page":"16755","DOI":"10.1523\/JNEUROSCI.4521-10.2010","volume":"30","author":"K Herrup","year":"2010","unstructured":"Herrup K (2010) Reimagining Alzheimer's disease\u2014an age-based hypothesis. J Neurosci 30(50):16755\u201316762","journal-title":"J Neurosci"},{"issue":"1","key":"8445_CR17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.55782\/ane-2004-1488","volume":"64","author":"C Zekanowski","year":"2004","unstructured":"Zekanowski C et al (2004) Genetic aspects of Alzheimer's disease. Acta Neurobiol Exp (Wars) 64(1):19\u201331","journal-title":"Acta Neurobiol Exp (Wars)"},{"issue":"5054","key":"8445_CR18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256(5054):184\u2013185","journal-title":"Science"},{"issue":"5","key":"8445_CR19","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/archpsyc.1987.01800170026005","volume":"44","author":"W Bondareff","year":"1987","unstructured":"Bondareff W et al (1987) Age and histopathologic heterogeneity in Alzheimer's disease. Evidence for subtypes. Arch Gen Psychiatry 44(5):412\u2013417","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"8445_CR20","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/archpsyc.1988.01800340090014","volume":"45","author":"DM Mann","year":"1988","unstructured":"Mann DM, Yates PO, Marcyniuk B (1988) Pathologic heterogeneity of Alzheimer's disease. Arch Gen Psychiatry 45(10):962\u2013963","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"8445_CR21","first-page":"5","volume":"49","author":"LC Walker","year":"2008","unstructured":"Walker LC, Rosen RF, Levine H 3rd (2008) Diversity of Abeta deposits in the aged brain: a window on molecular heterogeneity? Rom J Morphol Embryol 49(1):5\u201311","journal-title":"Rom J Morphol Embryol"},{"issue":"11","key":"8445_CR22","doi-asserted-by":"crossref","first-page":"e1000180","DOI":"10.1371\/journal.pmed.1000180","volume":"6","author":"FE Matthews","year":"2009","unstructured":"Matthews FE et al (2009) Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Med 6(11):e1000180","journal-title":"PLoS Med"},{"issue":"9251","key":"8445_CR23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(00)03589-3","volume":"357","author":"MRC-CFAS","year":"2001","unstructured":"MRC-CFAS (2001) Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 357(9251):169\u2013175","journal-title":"Lancet"},{"issue":"3","key":"8445_CR24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrn2091","volume":"8","author":"C Brayne","year":"2007","unstructured":"Brayne C (2007) The elephant in the room\u2014healthy brains in later life, epidemiology and public health. Nat Rev Neurosci 8(3):233\u2013239","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"8445_CR25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.arr.2010.10.002","volume":"10","author":"E Sikora","year":"2011","unstructured":"Sikora E et al (2011) Impact of cellular senescence signature on ageing research. Ageing Res Rev 10(1):146\u2013152","journal-title":"Ageing Res Rev"},{"key":"8445_CR26","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.2741\/4074","volume":"17","author":"J Vargas","year":"2012","unstructured":"Vargas J et al (2012) Senescence; an endogenous anticancer mechanism. Front Biosci 17:2616\u20132643","journal-title":"Front Biosci"},{"issue":"Suppl 1","key":"8445_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0625.2012.01493.x","volume":"21","author":"N Ohtani","year":"2012","unstructured":"Ohtani N et al (2012) Cellular senescence: a double-edged sword in the fight against cancer. Exp Dermatol 21(Suppl 1):1\u20134","journal-title":"Exp Dermatol"},{"issue":"16","key":"8445_CR28","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1038\/sj.onc.1207518","volume":"23","author":"JW Shay","year":"2004","unstructured":"Shay JW, Roninson IB (2004) Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23(16):2919\u20132933","journal-title":"Oncogene"},{"issue":"Pt 7","key":"8445_CR29","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1242\/jcs.113.7.1189","volume":"113","author":"W Bursch","year":"2000","unstructured":"Bursch W et al (2000) Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments. J Cell Sci 113(Pt 7):1189\u20131198","journal-title":"J Cell Sci"},{"issue":"7","key":"8445_CR30","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1586\/ern.10.84","volume":"10","author":"PI Moreira","year":"2010","unstructured":"Moreira PI et al (2010) Autophagy in Alzheimer's disease. Expert Rev Neurother 10(7):1209\u20131218","journal-title":"Expert Rev Neurother"},{"issue":"3","key":"8445_CR31","first-page":"263","volume":"27","author":"B Caballero","year":"2012","unstructured":"Caballero B, Coto-Montes A (2012) An insight into the role of autophagy in cell responses in the aging and neurodegenerative brain. Histol Histopathol 27(3):263\u2013275","journal-title":"Histol Histopathol"},{"issue":"7","key":"8445_CR32","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.neurobiolaging.2010.08.017","volume":"32","author":"D Mastroeni","year":"2011","unstructured":"Mastroeni D et al (2011) Epigenetic mechanisms in Alzheimer's disease. Neurobiol Aging 32(7):1161\u20131180","journal-title":"Neurobiol Aging"},{"issue":"2","key":"8445_CR33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10555-010-9220-9","volume":"29","author":"AR Davalos","year":"2010","unstructured":"Davalos AR et al (2010) Senescent cells as a source of inflammatory factors for tumor progression. Cancer Metastasis Rev 29(2):273\u2013283","journal-title":"Cancer Metastasis Rev"},{"key":"8445_CR34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1742-2094-5-45","volume":"5","author":"MK McCoy","year":"2008","unstructured":"McCoy MK, Tansey MG (2008) TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation 5:45","journal-title":"J Neuroinflammation"},{"issue":"3","key":"8445_CR35","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.pharmthera.2010.08.007","volume":"128","author":"IA Clark","year":"2010","unstructured":"Clark IA, Alleva LM, Vissel B (2010) The roles of TNF in brain dysfunction and disease. Pharmacol Ther 128(3):519\u2013548","journal-title":"Pharmacol Ther"},{"key":"8445_CR36","first-page":"756357","volume":"2012","author":"JM Rubio-Perez","year":"2012","unstructured":"Rubio-Perez JM, Morillas-Ruiz JM (2012) A review: inflammatory process in Alzheimer's disease, role of cytokines. Sci World J 2012:756357","journal-title":"Sci World J"},{"issue":"1\u20132","key":"8445_CR37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jneuroim.2004.01.005","volume":"150","author":"S Rosales-Corral","year":"2004","unstructured":"Rosales-Corral S et al (2004) Kinetics of the neuroinflammation-oxidative stress correlation in rat brain following the injection of fibrillar amyloid-beta onto the hippocampus in vivo. J Neuroimmunol 150(1\u20132):20\u201328","journal-title":"J Neuroimmunol"},{"issue":"22","key":"8445_CR38","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.1093\/nar\/gkm821","volume":"35","author":"MA Lovell","year":"2007","unstructured":"Lovell MA, Markesbery WR (2007) Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease. Nucleic Acids Res 35(22):7497\u20137504","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"8445_CR39","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/00001756-199507100-00020","volume":"6","author":"U Gartner","year":"1995","unstructured":"Gartner U et al (1995) Induction of p21ras in Alzheimer pathology. Neuroreport 6(10):1441\u20131444","journal-title":"Neuroreport"},{"issue":"18","key":"8445_CR40","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1097\/00001756-199611250-00050","volume":"7","author":"T Arendt","year":"1996","unstructured":"Arendt T et al (1996) Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease. Neuroreport 7(18):3047\u20133049","journal-title":"Neuroreport"},{"issue":"8\u20139","key":"8445_CR41","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s007020050104","volume":"105","author":"T Arendt","year":"1998","unstructured":"Arendt T, Holzer M, Gartner U (1998) Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease. J Neural Transm 105(8\u20139):949\u2013960","journal-title":"J Neural Transm"},{"issue":"1","key":"8445_CR42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0006-8993(99)02178-2","volume":"852","author":"HJ Luth","year":"2000","unstructured":"Luth HJ et al (2000) Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21ras and p16INK4a. Brain Res 852(1):45\u201355","journal-title":"Brain Res"},{"issue":"23","key":"8445_CR43","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1523\/JNEUROSCI.0651-06.2006","volume":"26","author":"C Alves da Costa","year":"2006","unstructured":"Alves da Costa C et al (2006) Presenilin-dependent gamma-secretase-mediated control of p53-associated cell death in Alzheimer's disease. J Neurosci 26(23):6377\u20136385","journal-title":"J Neurosci"},{"issue":"1","key":"8445_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0306-4522(99)00059-7","volume":"91","author":"U Gartner","year":"1999","unstructured":"Gartner U, Holzer M, Arendt T (1999) Elevated expression of p21ras is an early event in Alzheimer's disease and precedes neurofibrillary degeneration. Neuroscience 91(1):1\u20135","journal-title":"Neuroscience"},{"key":"8445_CR45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-2094-2-27","volume":"2","author":"JJ Hoozemans","year":"2005","unstructured":"Hoozemans JJ et al (2005) Maximal COX-2 and ppRb expression in neurons occurs during early Braak stages prior to the maximal activation of astrocytes and microglia in Alzheimer's disease. J Neuroinflammation 2:27","journal-title":"J Neuroinflammation"},{"issue":"2","key":"8445_CR46","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neuint.2008.10.013","volume":"54","author":"HG Lee","year":"2009","unstructured":"Lee HG et al (2009) Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease. Neurochem Int 54(2):84\u201388","journal-title":"Neurochem Int"},{"issue":"7","key":"8445_CR47","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ijdevneu.2004.07.007","volume":"22","author":"T Arendt","year":"2004","unstructured":"Arendt T (2004) Neurodegeneration and plasticity. Int J Dev Neurosci 22(7):507\u2013514","journal-title":"Int J Dev Neurosci"},{"issue":"1","key":"8445_CR48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3233\/JAD-2007-12107","volume":"12","author":"DA Butterfield","year":"2007","unstructured":"Butterfield DA, Sultana R (2007) Redox proteomics identification of oxidatively modified brain proteins in Alzheimer's disease and mild cognitive impairment: insights into the progression of this dementing disorder. J Alzheimers Dis 12(1):61\u201372","journal-title":"J Alzheimers Dis"},{"key":"8445_CR49","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0076-6879(07)00819-1","volume":"440","author":"DA Butterfield","year":"2008","unstructured":"Butterfield DA, Sultana R (2008) Identification of 3-nitrotyrosine-modified brain proteins by redox proteomics. Methods Enzymol 440:295\u2013308","journal-title":"Methods Enzymol"},{"issue":"1","key":"8445_CR50","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0165-0173(00)00051-5","volume":"35","author":"A Law","year":"2001","unstructured":"Law A, Gauthier S, Quirion R (2001) Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type. Brain Res Brain Res Rev 35(1):73\u201396","journal-title":"Brain Res Brain Res Rev"},{"issue":"30","key":"8445_CR51","doi-asserted-by":"crossref","first-page":"28294","DOI":"10.1074\/jbc.M212265200","volume":"278","author":"CA Marques","year":"2003","unstructured":"Marques CA et al (2003) Neurotoxic mechanisms caused by the Alzheimer's disease-linked Swedish amyloid precursor protein mutation: oxidative stress, caspases, and the JNK pathway. J Biol Chem 278(30):28294\u201328302","journal-title":"J Biol Chem"},{"key":"8445_CR52","doi-asserted-by":"crossref","first-page":"d1007","DOI":"10.2741\/gibson","volume":"7","author":"GE Gibson","year":"2002","unstructured":"Gibson GE, Huang HM (2002) Oxidative processes in the brain and non-neuronal tissues as biomarkers of Alzheimer's disease. Front Biosci 7:d1007\u2013d1015","journal-title":"Front Biosci"},{"issue":"1\u20132","key":"8445_CR53","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.brainres.2004.01.012","volume":"1000","author":"X Zhu","year":"2004","unstructured":"Zhu X et al (2004) Oxidative stress signalling in Alzheimer's disease. Brain Res 1000(1\u20132):32\u201339","journal-title":"Brain Res"},{"issue":"1\u20133","key":"8445_CR54","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1385\/MN:31:1-3:205","volume":"31","author":"X Zhu","year":"2005","unstructured":"Zhu X et al (2005) Oxidative imbalance in Alzheimer's disease. Mol Neurobiol 31(1\u20133):205\u2013217","journal-title":"Mol Neurobiol"},{"issue":"2","key":"8445_CR55","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nbd.2005.11.002","volume":"22","author":"DA Butterfield","year":"2006","unstructured":"Butterfield DA et al (2006) Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease. Neurobiol Dis 22(2):223\u2013232","journal-title":"Neurobiol Dis"},{"issue":"1","key":"8445_CR56","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-1998-1103","volume":"1","author":"G Perry","year":"1998","unstructured":"Perry G et al (1998) Reactive oxygen species mediate cellular damage in alzheimer disease. J Alzheimers Dis 1(1):45\u201355","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"8445_CR57","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","volume":"60","author":"A Nunomura","year":"2001","unstructured":"Nunomura A et al (2001) Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60(8):759\u2013767","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Suppl 1","key":"8445_CR58","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neurobiolaging.2005.08.008","volume":"26","author":"EG McGeer","year":"2005","unstructured":"McGeer EG, Klegeris A, McGeer PL (2005) Inflammation, the complement system and the diseases of aging. Neurobiol Aging 26(Suppl 1):94\u201397","journal-title":"Neurobiol Aging"},{"issue":"7","key":"8445_CR59","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1586\/ern.10.74","volume":"10","author":"HP Lee","year":"2010","unstructured":"Lee HP et al (2010) Antioxidant approaches for the treatment of Alzheimer's disease. Expert Rev Neurother 10(7):1201\u20131208","journal-title":"Expert Rev Neurother"},{"key":"8445_CR60","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-3-211-73574-9_27","volume":"72","author":"K Leuner","year":"2007","unstructured":"Leuner K et al (2007) Enhanced apoptosis, oxidative stress and mitochondrial dysfunction in lymphocytes as potential biomarkers for Alzheimer's disease. J Neural Transm Suppl 72:207\u2013215","journal-title":"J Neural Transm Suppl"},{"issue":"9","key":"8445_CR61","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1523\/JNEUROSCI.21-09-03017.2001","volume":"21","author":"K Hirai","year":"2001","unstructured":"Hirai K et al (2001) Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21(9):3017\u20133023","journal-title":"J Neurosci"},{"issue":"5\u20136","key":"8445_CR62","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.mito.2004.07.018","volume":"4","author":"G Aliev","year":"2004","unstructured":"Aliev G et al (2004) Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease. Mitochondrion 4(5\u20136):649\u2013663","journal-title":"Mitochondrion"},{"issue":"6","key":"8445_CR63","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/13550280290100978","volume":"8","author":"MP Mattson","year":"2002","unstructured":"Mattson MP (2002) Oxidative stress, perturbed calcium homeostasis, and immune dysfunction in Alzheimer's disease. J Neurovirol 8(6):539\u2013550","journal-title":"J Neurovirol"},{"issue":"1","key":"8445_CR64","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1113\/expphysiol.2007.038729","volume":"93","author":"E Hamel","year":"2008","unstructured":"Hamel E et al (2008) Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease. Exp Physiol 93(1):116\u2013120","journal-title":"Exp Physiol"},{"issue":"Suppl 1","key":"8445_CR65","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1097\/00002093-200000001-00012","volume":"14","author":"JC Torre de la","year":"2000","unstructured":"de la Torre JC (2000) Cerebral hypoperfusion, capillary degeneration, and development of Alzheimer disease. Alzheimer Dis Assoc Disord 14(Suppl 1):S72\u2013S81","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"7","key":"8445_CR66","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF03033159","volume":"5","author":"G Aliev","year":"2003","unstructured":"Aliev G et al (2003) Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease. Neurotox Res 5(7):491\u2013504","journal-title":"Neurotox Res"},{"issue":"7\u20138","key":"8445_CR67","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0736-5748(98)00082-3","volume":"16","author":"MP Mattson","year":"1998","unstructured":"Mattson MP, Pedersen WA (1998) Effects of amyloid precursor protein derivatives and oxidative stress on basal forebrain cholinergic systems in Alzheimer's disease. Int J Dev Neurosci 16(7\u20138):737\u2013753","journal-title":"Int J Dev Neurosci"},{"issue":"4","key":"8445_CR68","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.neuroscience.2008.08.022","volume":"156","author":"M Matos","year":"2008","unstructured":"Matos M et al (2008) Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades. Neuroscience 156(4):898\u2013910","journal-title":"Neuroscience"},{"issue":"3","key":"8445_CR69","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pneurobio.2005.02.004","volume":"75","author":"ZZ Chong","year":"2005","unstructured":"Chong ZZ, Li F, Maiese K (2005) Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease. Prog Neurobiol 75(3):207\u2013246","journal-title":"Prog Neurobiol"},{"issue":"6","key":"8445_CR70","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn3230","volume":"13","author":"M Yeoman","year":"2012","unstructured":"Yeoman M, Scutt G, Faragher R (2012) Insights into CNS ageing from animal models of senescence. Nat Rev Neurosci 13(6):435\u2013445","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"8445_CR71","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2006.06.026","volume":"545","author":"DA Butterfield","year":"2006","unstructured":"Butterfield DA, Perluigi M, Sultana R (2006) Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics. Eur J Pharmacol 545(1):39\u201350","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"8445_CR72","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/156720506775697124","volume":"3","author":"HG Lee","year":"2006","unstructured":"Lee HG et al (2006) Amyloid beta: the alternate hypothesis. Curr Alzheimer Res 3(1):75\u201380","journal-title":"Curr Alzheimer Res"},{"issue":"6","key":"8445_CR73","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0197-4580(02)00050-7","volume":"23","author":"GM Bishop","year":"2002","unstructured":"Bishop GM, Robinson SR (2002) The amyloid hypothesis: let sleeping dogmas lie? Neurobiol Aging 23(6):1101\u20131105","journal-title":"Neurobiol Aging"},{"issue":"4","key":"8445_CR74","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1750-3639.2004.tb00087.x","volume":"14","author":"DA Butterfield","year":"2004","unstructured":"Butterfield DA, Boyd-Kimball D (2004) Amyloid beta-peptide(1\u201342) contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain. Brain Pathol 14(4):426\u2013432","journal-title":"Brain Pathol"},{"issue":"5","key":"8445_CR75","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.cellsig.2012.01.008","volume":"24","author":"PD Ray","year":"2012","unstructured":"Ray PD, Huang BW, Tsuji Y (2012) Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 24(5):981\u2013990","journal-title":"Cell Signal"},{"issue":"6","key":"8445_CR76","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1089\/ars.2010.3652","volume":"15","author":"MF Ladelfa","year":"2011","unstructured":"Ladelfa MF et al (2011) Interaction of p53 with tumor suppressive and oncogenic signaling pathways to control cellular reactive oxygen species production. Antioxid Redox Signal 15(6):1749\u20131761","journal-title":"Antioxid Redox Signal"},{"key":"8445_CR77","doi-asserted-by":"crossref","first-page":"467180","DOI":"10.1155\/2011\/467180","volume":"2011","author":"A Melo","year":"2011","unstructured":"Melo A et al (2011) Oxidative stress in neurodegenerative diseases: mechanisms and therapeutic perspectives. Oxidative Med Cell Longev 2011:467180","journal-title":"Oxidative Med Cell Longev"},{"issue":"3","key":"8445_CR78","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","volume":"21","author":"H Akiyama","year":"2000","unstructured":"Akiyama H et al (2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21(3):383\u2013421","journal-title":"Neurobiol Aging"},{"issue":"8","key":"8445_CR79","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jpsychires.2008.10.006","volume":"43","author":"J Popp","year":"2009","unstructured":"Popp J et al (2009) Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease. J Psychiatr Res 43(8):749\u2013753","journal-title":"J Psychiatr Res"},{"issue":"1","key":"8445_CR80","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0006-8993(03)02881-6","volume":"982","author":"MR D'Andrea","year":"2003","unstructured":"D'Andrea MR (2003) Evidence linking neuronal cell death to autoimmunity in Alzheimer's disease. Brain Res 982(1):19\u201330","journal-title":"Brain Res"},{"issue":"6","key":"8445_CR81","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.pneurobio.2003.08.001","volume":"70","author":"Y Shen","year":"2003","unstructured":"Shen Y, Meri S (2003) Yin and Yang: complement activation and regulation in Alzheimer's disease. Prog Neurobiol 70(6):463\u2013472","journal-title":"Prog Neurobiol"},{"key":"8445_CR82","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1742-2094-5-51","volume":"5","author":"B Giunta","year":"2008","unstructured":"Giunta B et al (2008) Inflammaging as a prodrome to Alzheimer's disease. J Neuroinflammation 5:51","journal-title":"J Neuroinflammation"},{"issue":"3","key":"8445_CR83","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/157488711796575577","volume":"6","author":"V Pizza","year":"2011","unstructured":"Pizza V et al (2011) Neuroinflammation and ageing: current theories and an overview of the data. Rev Recent Clin Trials 6(3):189\u2013203","journal-title":"Rev Recent Clin Trials"},{"issue":"2\u20133","key":"8445_CR84","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijdevneu.2005.11.001","volume":"24","author":"JJ Hoozemans","year":"2006","unstructured":"Hoozemans JJ et al (2006) Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology. Int J Dev Neurosci 24(2\u20133):157\u2013165","journal-title":"Int J Dev Neurosci"},{"issue":"9","key":"8445_CR85","first-page":"1005","volume":"12","author":"T Wyss-Coray","year":"2006","unstructured":"Wyss-Coray T (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 12(9):1005\u20131015","journal-title":"Nat Med"},{"key":"8445_CR86","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/1-4020-5688-5_11","volume":"42","author":"CA Szekely","year":"2007","unstructured":"Szekely CA, Town T, Zandi PP (2007) NSAIDs for the chemoprevention of Alzheimer's disease. Subcell Biochem 42:229\u2013248","journal-title":"Subcell Biochem"},{"issue":"5","key":"8445_CR87","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neurobiolaging.2006.03.013","volume":"28","author":"PL McGeer","year":"2007","unstructured":"McGeer PL, McGeer EG (2007) NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies. Neurobiol Aging 28(5):639\u2013647","journal-title":"Neurobiol Aging"},{"issue":"8","key":"8445_CR88","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/glia.20973","volume":"58","author":"T Malm","year":"2010","unstructured":"Malm T et al (2010) The role and therapeutic potential of monocytic cells in Alzheimer's disease. Glia 58(8):889\u2013900","journal-title":"Glia"},{"issue":"9","key":"8445_CR89","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.febslet.2005.02.048","volume":"579","author":"S Ito","year":"2005","unstructured":"Ito S et al (2005) Amyloid-beta peptides induce cell proliferation and macrophage colony-stimulating factor expression via the PI3-kinase\/Akt pathway in cultured Ra2 microglial cells. FEBS Lett 579(9):1995\u20132000","journal-title":"FEBS Lett"},{"issue":"8","key":"8445_CR90","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00702-010-0433-4","volume":"117","author":"CY Lee","year":"2010","unstructured":"Lee CY, Landreth GE (2010) The role of microglia in amyloid clearance from the AD brain. J Neural Transm 117(8):949\u2013960","journal-title":"J Neural Transm"},{"issue":"6","key":"8445_CR91","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1096\/fj.01-0530fje","volume":"16","author":"J Kakimura","year":"2002","unstructured":"Kakimura J et al (2002) Microglial activation and amyloid-beta clearance induced by exogenous heat-shock proteins. FASEB J 16(6):601\u2013603","journal-title":"FASEB J"},{"issue":"3","key":"8445_CR92","doi-asserted-by":"crossref","first-page":"187","DOI":"10.18632\/aging.100440","volume":"4","author":"YC Shang","year":"2012","unstructured":"Shang YC et al (2012) Prevention of beta-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K\/mTOR pathway, Bad, and Bcl-xL. Aging (Albany NY) 4(3):187\u2013201","journal-title":"Aging (Albany NY)"},{"issue":"1\u20132","key":"8445_CR93","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.brainres.2004.06.058","volume":"1022","author":"J Wegiel","year":"2004","unstructured":"Wegiel J et al (2004) Cells of monocyte\/microglial lineage are involved in both microvessel amyloidosis and fibrillar plaque formation in APPsw tg mice. Brain Res 1022(1\u20132):19\u201329","journal-title":"Brain Res"},{"issue":"10","key":"8445_CR94","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1523\/JNEUROSCI.4998-04.2005","volume":"25","author":"AM Floden","year":"2005","unstructured":"Floden AM, Li S, Combs CK (2005) Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors. J Neurosci 25(10):2566\u20132575","journal-title":"J Neurosci"},{"issue":"4","key":"8445_CR95","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF03033906","volume":"12","author":"R Bernhardi von","year":"2007","unstructured":"von Bernhardi R (2007) Glial cell dysregulation: a new perspective on Alzheimer disease. Neurotox Res 12(4):215\u2013232","journal-title":"Neurotox Res"},{"issue":"9","key":"8445_CR96","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/01.jnen.0000178444.33972.e0","volume":"64","author":"D Morgan","year":"2005","unstructured":"Morgan D et al (2005) Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: implications for Alzheimer therapeutics. J Neuropathol Exp Neurol 64(9):743\u2013753","journal-title":"J Neuropathol Exp Neurol"},{"key":"8445_CR97","doi-asserted-by":"crossref","unstructured":"Merlini M et al (2011) Vascular beta-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAbeta mice. Acta Neuropathol 122(3):293\u2013311","DOI":"10.1007\/s00401-011-0834-y"},{"issue":"2","key":"8445_CR98","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neulet.2009.06.013","volume":"461","author":"B Wu","year":"2009","unstructured":"Wu B et al (2009) RAGE, LDL receptor, and LRP1 expression in the brains of SAMP8. Neurosci Lett 461(2):100\u2013105","journal-title":"Neurosci Lett"},{"issue":"9","key":"8445_CR99","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/NEN.0b013e3181836a71","volume":"67","author":"S Utter","year":"2008","unstructured":"Utter S et al (2008) Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes. J Neuropathol Exp Neurol 67(9):842\u2013856","journal-title":"J Neuropathol Exp Neurol"},{"issue":"16","key":"8445_CR100","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.2174\/138161208784705487","volume":"14","author":"R Deane","year":"2008","unstructured":"Deane R, Sagare A, Zlokovic BV (2008) The role of the cell surface LRP and soluble LRP in blood\u2013brain barrier Abeta clearance in Alzheimer's disease. Curr Pharm Des 14(16):1601\u20131605","journal-title":"Curr Pharm Des"},{"key":"8445_CR101","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.brainres.2009.12.039","volume":"1315","author":"IB Bruinsma","year":"2010","unstructured":"Bruinsma IB et al (2010) Apolipoprotein E protects cultured pericytes and astrocytes from D-Abeta(1\u201340)-mediated cell death. Brain Res 1315:169\u2013180","journal-title":"Brain Res"},{"issue":"4","key":"8445_CR102","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/1097-0029(20000815)50:4<297::AID-JEMT9>3.0.CO;2-C","volume":"50","author":"AM Fagan","year":"2000","unstructured":"Fagan AM, Holtzman DM (2000) Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo. Microsc Res Tech 50(4):297\u2013304","journal-title":"Microsc Res Tech"},{"issue":"6","key":"8445_CR103","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.2353\/ajpath.2007.070050","volume":"171","author":"MM Wilhelmus","year":"2007","unstructured":"Wilhelmus MM et al (2007) Lipoprotein receptor-related protein-1 mediates amyloid-beta-mediated cell death of cerebrovascular cells. Am J Pathol 171(6):1989\u20131999","journal-title":"Am J Pathol"},{"issue":"12","key":"8445_CR104","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1172\/JCI36663","volume":"118","author":"R Deane","year":"2008","unstructured":"Deane R et al (2008) apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest 118(12):4002\u20134013","journal-title":"J Clin Invest"},{"issue":"6 Pt B","key":"8445_CR105","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1006\/nbdi.2000.0321","volume":"7","author":"I Blasko","year":"2000","unstructured":"Blasko I et al (2000) Costimulatory effects of interferon-gamma and interleukin-1beta or tumor necrosis factor alpha on the synthesis of Abeta1-40 and Abeta1-42 by human astrocytes. Neurobiol Dis 7(6 Pt B):682\u2013689","journal-title":"Neurobiol Dis"},{"issue":"2","key":"8445_CR106","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0006-8993(03)02361-8","volume":"971","author":"RG Nagele","year":"2003","unstructured":"Nagele RG et al (2003) Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains. Brain Res 971(2):197\u2013209","journal-title":"Brain Res"},{"issue":"4","key":"8445_CR107","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1073\/pnas.0805453106","volume":"106","author":"CA Hawkes","year":"2009","unstructured":"Hawkes CA, McLaurin J (2009) Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proc Natl Acad Sci U S A 106(4):1261\u20131266","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"8445_CR108","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/1568010053586237","volume":"4","author":"GJ Ho","year":"2005","unstructured":"Ho GJ et al (2005) Mechanisms of cell signaling and inflammation in Alzheimer's disease. Curr Drug Targets Inflamm Allergy 4(2):247\u2013256","journal-title":"Curr Drug Targets Inflamm Allergy"},{"issue":"45","key":"8445_CR109","doi-asserted-by":"crossref","first-page":"46907","DOI":"10.1074\/jbc.M409544200","volume":"279","author":"V Beglopoulos","year":"2004","unstructured":"Beglopoulos V et al (2004) Reduced beta-amyloid production and increased inflammatory responses in presenilin conditional knock-out mice. J Biol Chem 279(45):46907\u201346914","journal-title":"J Biol Chem"},{"issue":"4","key":"8445_CR110","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0022-2275(20)32409-3","volume":"41","author":"DT Laskowitz","year":"2000","unstructured":"Laskowitz DT et al (2000) Altered immune responses in apolipoprotein E-deficient mice. J Lipid Res 41(4):613\u2013620","journal-title":"J Lipid Res"},{"key":"8445_CR111","first-page":"949072","volume":"2011","author":"H Zhang","year":"2011","unstructured":"Zhang H, Wu LM, Wu J (2011) Cross-talk between apolipoprotein E and cytokines. Mediat Inflamm 2011:949072","journal-title":"Mediat Inflamm"},{"issue":"2","key":"8445_CR112","first-page":"147","volume":"24","author":"J Poirier","year":"1999","unstructured":"Poirier J (1999) Apolipoprotein E4, cholinergic integrity and the pharmacogenetics of Alzheimer's disease. J Psychiatry Neurosci 24(2):147\u2013153","journal-title":"J Psychiatry Neurosci"},{"issue":"Pt 5","key":"8445_CR113","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1042\/BST0331033","volume":"33","author":"TJ Nelson","year":"2005","unstructured":"Nelson TJ, Alkon DL (2005) Insulin and cholesterol pathways in neuronal function, memory and neurodegeneration. Biochem Soc Trans 33(Pt 5):1033\u20131036","journal-title":"Biochem Soc Trans"},{"issue":"Pt 1","key":"8445_CR114","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/bj20020207","volume":"366","author":"NM Bentley","year":"2002","unstructured":"Bentley NM et al (2002) Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1\u201340): the role of salt bridges. Biochem J 366(Pt 1):273\u2013279","journal-title":"Biochem J"},{"issue":"3","key":"8445_CR115","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1046\/j.1471-4159.2000.0741008.x","volume":"74","author":"M Michikawa","year":"2000","unstructured":"Michikawa M et al (2000) Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture. J Neurochem 74(3):1008\u20131016","journal-title":"J Neurochem"},{"issue":"5","key":"8445_CR116","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.neurobiolaging.2003.12.024","volume":"25","author":"DK Lahiri","year":"2004","unstructured":"Lahiri DK, Sambamurti K, Bennett DA (2004) Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease. Neurobiol Aging 25(5):651\u2013660","journal-title":"Neurobiol Aging"},{"issue":"3","key":"8445_CR117","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7326\/0003-4819-137-3-200208060-00006","volume":"137","author":"M Kivipelto","year":"2002","unstructured":"Kivipelto M et al (2002) Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med 137(3):149\u2013155","journal-title":"Ann Intern Med"},{"issue":"Pt 2","key":"8445_CR118","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/0264-6021:3480359","volume":"348","author":"T Tokuda","year":"2000","unstructured":"Tokuda T et al (2000) Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides. Biochem J 348(Pt 2):359\u2013365","journal-title":"Biochem J"},{"issue":"18","key":"8445_CR119","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1021\/bi702097s","volume":"47","author":"S Tamamizu-Kato","year":"2008","unstructured":"Tamamizu-Kato S et al (2008) Interaction with amyloid beta peptide compromises the lipid binding function of apolipoprotein E. Biochemistry 47(18):5225\u20135234","journal-title":"Biochemistry"},{"issue":"2","key":"8445_CR120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1515\/REVNEURO.2005.16.2.123","volume":"16","author":"CV Zerbinatti","year":"2005","unstructured":"Zerbinatti CV, Bu G (2005) LRP and Alzheimer's disease. Rev Neurosci 16(2):123\u2013135","journal-title":"Rev Neurosci"},{"key":"8445_CR121","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1196\/annals.1377.005","volume":"1086","author":"G Bu","year":"2006","unstructured":"Bu G, Cam J, Zerbinatti C (2006) LRP in amyloid-beta production and metabolism. Ann N Y Acad Sci 1086:35\u201353","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"8445_CR122","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/156720508783884675","volume":"5","author":"S Jaeger","year":"2008","unstructured":"Jaeger S, Pietrzik CU (2008) Functional role of lipoprotein receptors in Alzheimer's disease. Curr Alzheimer Res 5(1):15\u201325","journal-title":"Curr Alzheimer Res"},{"issue":"21","key":"8445_CR123","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1093\/emboj\/cdf568","volume":"21","author":"CU Pietrzik","year":"2002","unstructured":"Pietrzik CU et al (2002) The cytoplasmic domain of the LDL receptor-related protein regulates multiple steps in APP processing. EMBO J 21(21):5691\u20135700","journal-title":"EMBO J"},{"issue":"29","key":"8445_CR124","doi-asserted-by":"crossref","first-page":"27303","DOI":"10.1074\/jbc.M413969200","volume":"280","author":"A Lleo","year":"2005","unstructured":"Lleo A et al (2005) Low density lipoprotein receptor-related protein (LRP) interacts with presenilin 1 and is a competitive substrate of the amyloid precursor protein (APP) for gamma-secretase. J Biol Chem 280(29):27303\u201327309","journal-title":"J Biol Chem"},{"issue":"5","key":"8445_CR125","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","volume":"58","author":"Q Jiang","year":"2008","unstructured":"Jiang Q et al (2008) ApoE promotes the proteolytic degradation of Abeta. Neuron 58(5):681\u2013693","journal-title":"Neuron"},{"issue":"1\u20132","key":"8445_CR126","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jns.2010.08.030","volume":"299","author":"J Attems","year":"2010","unstructured":"Attems J et al (2010) Capillary CAA and perivascular Abeta-deposition: two distinct features of Alzheimer's disease pathology. J Neurol Sci 299(1\u20132):155\u2013162","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"8445_CR127","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0006-8993(03)03026-9","volume":"983","author":"B Mazur-Kolecka","year":"2003","unstructured":"Mazur-Kolecka B et al (2003) The effect of oxidative stress on accumulation of apolipoprotein E3 and E4 in a cell culture model of beta-amyloid angiopathy (CAA). Brain Res 983(1\u20132):48\u201357","journal-title":"Brain Res"},{"issue":"2","key":"8445_CR128","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1385\/JMN:17:2:147","volume":"17","author":"DM Holtzman","year":"2001","unstructured":"Holtzman DM (2001) Role of apoe\/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy. J Mol Neurosci 17(2):147\u2013155","journal-title":"J Mol Neurosci"},{"key":"8445_CR129","first-page":"CD005593","volume":"1","author":"J Birks","year":"2006","unstructured":"Birks J (2006) Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev 1:CD005593","journal-title":"Cochrane Database Syst Rev"},{"key":"8445_CR130","first-page":"367","volume":"4","author":"SJ Thomas","year":"2009","unstructured":"Thomas SJ, Grossberg GT (2009) Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias. Clin Interv Aging 4:367\u2013377","journal-title":"Clin Interv Aging"},{"issue":"1","key":"8445_CR131","first-page":"13","volume":"28","author":"KL Lanctot","year":"2003","unstructured":"Lanctot KL, Herrmann N, LouLou MM (2003) Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease. J Psychiatry Neurosci 28(1):13\u201326","journal-title":"J Psychiatry Neurosci"},{"issue":"7\u20138","key":"8445_CR132","first-page":"1003","volume":"109","author":"L Frolich","year":"2002","unstructured":"Frolich L (2002) The cholinergic pathology in Alzheimer's disease\u2014discrepancies between clinical experience and pathophysiological findings. J Neural Transm 109(7\u20138):1003\u20131013","journal-title":"J Neural Transm"},{"issue":"6","key":"8445_CR133","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1037\/1064-1297.15.6.546","volume":"15","author":"G Brousseau","year":"2007","unstructured":"Brousseau G, Rourke BP, Burke B (2007) Acetylcholinesterase inhibitors, neuropsychiatric symptoms, and Alzheimer's disease subtypes: an alternate hypothesis to global cognitive enhancement. Exp Clin Psychopharmacol 15(6):546\u2013554","journal-title":"Exp Clin Psychopharmacol"},{"issue":"11","key":"8445_CR134","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00702-006-0579-2","volume":"113","author":"R Schliebs","year":"2006","unstructured":"Schliebs R, Arendt T (2006) The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J Neural Transm 113(11):1625\u20131644","journal-title":"J Neural Transm"},{"issue":"2","key":"8445_CR135","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.bbr.2010.11.058","volume":"221","author":"R Schliebs","year":"2011","unstructured":"Schliebs R, Arendt T (2011) The cholinergic system in aging and neuronal degeneration. Behav Brain Res 221(2):555\u2013563","journal-title":"Behav Brain Res"},{"issue":"4","key":"8445_CR136","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0891-0618(03)00068-1","volume":"26","author":"EJ Mufson","year":"2003","unstructured":"Mufson EJ et al (2003) Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction. J Chem Neuroanat 26(4):233\u2013242","journal-title":"J Chem Neuroanat"},{"issue":"Suppl 1","key":"8445_CR137","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1007\/s00259-007-0699-4","volume":"35","author":"K Herholz","year":"2008","unstructured":"Herholz K (2008) Acetylcholine esterase activity in mild cognitive impairment and Alzheimer's disease. Eur J Nucl Med Mol Imaging 35(Suppl 1):S25\u2013S29","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"8445_CR138","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.neuropsychologia.2007.11.024","volume":"46","author":"K Herholz","year":"2008","unstructured":"Herholz K, Weisenbach S, Kalbe E (2008) Deficits of the cholinergic system in early AD. Neuropsychologia 46(6):1642\u20131647","journal-title":"Neuropsychologia"},{"issue":"15","key":"8445_CR139","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/jama.281.15.1401","volume":"281","author":"KL Davis","year":"1999","unstructured":"Davis KL et al (1999) Cholinergic markers in elderly patients with early signs of Alzheimer disease. JAMA 281(15):1401\u20131406","journal-title":"JAMA"},{"issue":"3","key":"8445_CR140","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/jpet.102.041616","volume":"306","author":"AV Terry Jr","year":"2003","unstructured":"Terry AV Jr, Buccafusco JJ (2003) The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J Pharmacol Exp Ther 306(3):821\u2013827","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"8445_CR141","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.20100","volume":"55","author":"M Mesulam","year":"2004","unstructured":"Mesulam M et al (2004) Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann Neurol 55(6):815\u2013828","journal-title":"Ann Neurol"},{"issue":"Pt 1","key":"8445_CR142","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/brain\/awh671","volume":"129","author":"R Goekoop","year":"2006","unstructured":"Goekoop R et al (2006) Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation\u2014a pharmacological fMRI study. Brain 129(Pt 1):141\u2013157","journal-title":"Brain"},{"issue":"1","key":"8445_CR143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-008-1092-0","volume":"198","author":"EL Schaeffer","year":"2008","unstructured":"Schaeffer EL, Gattaz WF (2008) Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme. Psychopharmacology (Berlin) 198(1):1\u201327","journal-title":"Psychopharmacology (Berlin)"},{"issue":"4","key":"8445_CR144","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.molmed.2005.02.008","volume":"11","author":"HG Lee","year":"2005","unstructured":"Lee HG et al (2005) Tau phosphorylation in Alzheimer's disease: pathogen or protector? Trends Mol Med 11(4):164\u2013169","journal-title":"Trends Mol Med"},{"issue":"6","key":"8445_CR145","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2174\/156720511796717131","volume":"8","author":"DJ Bonda","year":"2011","unstructured":"Bonda DJ et al (2011) A novel perspective on tau in Alzheimer's disease. Curr Alzheimer Res 8(6):639\u2013642","journal-title":"Curr Alzheimer Res"},{"issue":"4","key":"8445_CR146","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3233\/JAD-2008-14408","volume":"14","author":"CA Rankin","year":"2008","unstructured":"Rankin CA, Gamblin TC (2008) Assessing the toxicity of tau aggregation. J Alzheimers Dis 14(4):411\u2013416","journal-title":"J Alzheimers Dis"},{"issue":"2\u20133","key":"8445_CR147","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bbadis.2004.10.011","volume":"1739","author":"KS Kosik","year":"2005","unstructured":"Kosik KS, Shimura H (2005) Phosphorylated tau and the neurodegenerative foldopathies. Biochim Biophys Acta 1739(2\u20133):298\u2013310","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"8445_CR148","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1474-9726.2011.00778.x","volume":"11","author":"V Khurana","year":"2012","unstructured":"Khurana V et al (2012) A neuroprotective role for the DNA damage checkpoint in tauopathy. Aging Cell 11(2):360\u2013362","journal-title":"Aging Cell"},{"issue":"8","key":"8445_CR149","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2174\/156720510793611637","volume":"7","author":"S Souter","year":"2010","unstructured":"Souter S, Lee G (2010) Tubulin-independent tau in Alzheimer's disease and cancer: implications for disease pathogenesis and treatment. Curr Alzheimer Res 7(8):697\u2013707","journal-title":"Curr Alzheimer Res"},{"issue":"2","key":"8445_CR150","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/jemt.1075","volume":"53","author":"RL Bleys","year":"2001","unstructured":"Bleys RL, Cowen T (2001) Innervation of cerebral blood vessels: morphology, plasticity, age-related, and Alzheimer's disease-related neurodegeneration. Microsc Res Tech 53(2):106\u2013118","journal-title":"Microsc Res Tech"},{"issue":"5","key":"8445_CR151","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/1389450111209050656","volume":"13","author":"W Lin","year":"2012","unstructured":"Lin W et al (2012) Role of alpha7-nicotinic acetylcholine receptor in normal and cancer stem cells. Curr Drug Targets 13(5):656\u2013665","journal-title":"Curr Drug Targets"},{"issue":"20","key":"8445_CR152","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.4161\/cc.5.20.3366","volume":"5","author":"P Dasgupta","year":"2006","unstructured":"Dasgupta P, Chellappan SP (2006) Nicotine-mediated cell proliferation and angiogenesis: new twists to an old story. Cell Cycle 5(20):2324\u20132328","journal-title":"Cell Cycle"},{"key":"8445_CR153","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1749-6632.1999.tb07821.x","volume":"893","author":"RN Kalaria","year":"1999","unstructured":"Kalaria RN (1999) The blood\u2013brain barrier and cerebrovascular pathology in Alzheimer's disease. Ann N Y Acad Sci 893:113\u2013125","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"8445_CR154","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2990.2010.01139.x","volume":"37","author":"WR Brown","year":"2011","unstructured":"Brown WR, Thore CR (2011) Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol 37(1):56\u201374","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"6","key":"8445_CR155","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0301-0082(00)00068-X","volume":"64","author":"E Farkas","year":"2001","unstructured":"Farkas E, Luiten PG (2001) Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol 64(6):575\u2013611","journal-title":"Prog Neurobiol"},{"issue":"6","key":"8445_CR156","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1161\/01.STR.0000221308.94473.14","volume":"37","author":"MS Fernando","year":"2006","unstructured":"Fernando MS et al (2006) White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke 37(6):1391\u20131398","journal-title":"Stroke"},{"key":"8445_CR157","doi-asserted-by":"crossref","unstructured":"Bell RD, Zlokovic BV (2009) Neurovascular mechanisms and blood\u2013brain barrier disorder in Alzheimer's disease. Acta Neuropathol 118(1):103\u2013113","DOI":"10.1007\/s00401-009-0522-3"},{"issue":"6","key":"8445_CR158","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00401-008-0366-2","volume":"115","author":"DR Thal","year":"2008","unstructured":"Thal DR et al (2008) Cerebral amyloid angiopathy and its relationship to Alzheimer's disease. Acta Neuropathol 115(6):599\u2013609","journal-title":"Acta Neuropathol"},{"issue":"3","key":"8445_CR159","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/jnen\/61.3.282","volume":"61","author":"DR Thal","year":"2002","unstructured":"Thal DR et al (2002) Two types of sporadic cerebral amyloid angiopathy. J Neuropathol Exp Neurol 61(3):282\u2013293","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"8445_CR160","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00401-010-0707-9","volume":"120","author":"DR Thal","year":"2010","unstructured":"Thal DR et al (2010) Capillary cerebral amyloid angiopathy identifies a distinct APOE epsilon4-associated subtype of sporadic Alzheimer's disease. Acta Neuropathol 120(2):169\u2013183","journal-title":"Acta Neuropathol"},{"issue":"1","key":"8445_CR161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-008-0457-0","volume":"117","author":"RO Weller","year":"2009","unstructured":"Weller RO et al (2009) Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol 117(1):1\u201314","journal-title":"Acta Neuropathol"},{"key":"8445_CR162","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1749-6632.2000.tb06344.x","volume":"903","author":"HM Wisniewski","year":"2000","unstructured":"Wisniewski HM et al (2000) Role of perivascular cells and myocytes in vascular amyloidosis. Ann N Y Acad Sci 903:6\u201318","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"8445_CR163","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tins.2005.02.001","volume":"28","author":"BV Zlokovic","year":"2005","unstructured":"Zlokovic BV (2005) Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci 28(4):202\u2013208","journal-title":"Trends Neurosci"},{"issue":"7","key":"8445_CR164","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1096\/fj.09-146456","volume":"24","author":"S Donnini","year":"2010","unstructured":"Donnini S et al (2010) Abeta peptides accelerate the senescence of endothelial cells in vitro and in vivo, impairing angiogenesis. FASEB J 24(7):2385\u20132395","journal-title":"FASEB J"},{"issue":"4","key":"8445_CR165","first-page":"581","volume":"19","author":"E Boscolo","year":"2007","unstructured":"Boscolo E et al (2007) Beta amyloid angiogenic activity in vitro and in vivo. Int J Mol Med 19(4):581\u2013587","journal-title":"Int J Mol Med"},{"issue":"11\u201312","key":"8445_CR166","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1089\/ars.2006.8.1997","volume":"8","author":"MP Mattson","year":"2006","unstructured":"Mattson MP (2006) Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders. Antioxid Redox Signal 8(11\u201312):1997\u20132006","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"8445_CR167","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/039463201202500204","volume":"25","author":"M Verri","year":"2012","unstructured":"Verri M et al (2012) Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease. Int J Immunopathol Pharmacol 25(2):345\u2013353","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1\u20132","key":"8445_CR168","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.exger.2006.08.009","volume":"42","author":"GM Cole","year":"2007","unstructured":"Cole GM, Frautschy SA (2007) The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer's Disease. Exp Gerontol 42(1\u20132):10\u201321","journal-title":"Exp Gerontol"},{"issue":"1","key":"8445_CR169","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3233\/JAD-2010-1211","volume":"19","author":"A Erol","year":"2010","unstructured":"Erol A (2010) Are paradoxical cell cycle activities in neurons and glia related to the metabolic theory of Alzheimer's disease? J Alzheimers Dis 19(1):129\u2013135","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"8445_CR170","doi-asserted-by":"crossref","first-page":"a001057","DOI":"10.1101\/cshperspect.a001057","volume":"2","author":"Z Feng","year":"2010","unstructured":"Feng Z (2010) p53 regulation of the IGF-1\/AKT\/mTOR pathways and the endosomal compartment. Cold Spring Harb Perspect Biol 2(2):a001057","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"Pt 1","key":"8445_CR171","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1042\/BST0370213","volume":"37","author":"DC Goberdhan","year":"2009","unstructured":"Goberdhan DC, Boyd CA (2009) mTOR: dissecting regulation and mechanism of action to understand human disease. Biochem Soc Trans 37(Pt 1):213\u2013216","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"8445_CR172","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2796.2010.02281.x","volume":"269","author":"F Sofi","year":"2011","unstructured":"Sofi F et al (2011) Physical activity and risk of cognitive decline: a meta-analysis of prospective studies. J Intern Med 269(1):107\u2013117","journal-title":"J Intern Med"},{"issue":"14","key":"8445_CR173","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2165\/00007256-200333140-00001","volume":"33","author":"A Maiorana","year":"2003","unstructured":"Maiorana A et al (2003) Exercise and the nitric oxide vasodilator system. Sports Med 33(14):1013\u20131035","journal-title":"Sports Med"},{"issue":"5","key":"8445_CR174","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1139\/H07-081","volume":"32","author":"Z Radak","year":"2007","unstructured":"Radak Z et al (2007) Effects of exercise on brain function: role of free radicals. Appl Physiol Nutr Metab 32(5):942\u2013946","journal-title":"Appl Physiol Nutr Metab"},{"issue":"4","key":"8445_CR175","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s12264-008-0402-1","volume":"24","author":"Q Ma","year":"2008","unstructured":"Ma Q (2008) Beneficial effects of moderate voluntary physical exercise and its biological mechanisms on brain health. Neurosci Bull 24(4):265\u2013270","journal-title":"Neurosci Bull"},{"issue":"32","key":"8445_CR176","doi-asserted-by":"crossref","first-page":"11578","DOI":"10.1523\/JNEUROSCI.2266-11.2011","volume":"31","author":"RM Barrientos","year":"2011","unstructured":"Barrientos RM et al (2011) Little exercise, big effects: reversing aging and infection-induced memory deficits, and underlying processes. J Neurosci 31(32):11578\u201311586","journal-title":"J Neurosci"},{"issue":"10","key":"8445_CR177","doi-asserted-by":"crossref","first-page":"e7506","DOI":"10.1371\/journal.pone.0007506","volume":"4","author":"KT Gobeske","year":"2009","unstructured":"Gobeske KT et al (2009) BMP signaling mediates effects of exercise on hippocampal neurogenesis and cognition in mice. PLoS One 4(10):e7506","journal-title":"PLoS One"},{"issue":"1","key":"8445_CR178","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1152\/ajpendo.00027.2012","volume":"303","author":"K Gohil","year":"2012","unstructured":"Gohil K, Brooks GA (2012) Exercise tames the wild side of the Myc network: a hypothesis. Am J Physiol Endocrinol Metab 303(1):E18\u2013E30","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"8445_CR179","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/PHM.0b013e318214de26","volume":"90","author":"H Littbrand","year":"2011","unstructured":"Littbrand H, Stenvall M, Rosendahl E (2011) Applicability and effects of physical exercise on physical and cognitive functions and activities of daily living among people with dementia: a systematic review. Am J Phys Med Rehabil 90(6):495\u2013518","journal-title":"Am J Phys Med Rehabil"},{"issue":"1","key":"8445_CR180","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00702-002-0766-8","volume":"110","author":"V Solfrizzi","year":"2003","unstructured":"Solfrizzi V, Panza F, Capurso A (2003) The role of diet in cognitive decline. J Neural Transm 110(1):95\u2013110","journal-title":"J Neural Transm"},{"issue":"6\u20137","key":"8445_CR181","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s11064-005-6967-4","volume":"30","author":"JA Joseph","year":"2005","unstructured":"Joseph JA et al (2005) Oxidative stress and inflammation in brain aging: nutritional considerations. Neurochem Res 30(6\u20137):927\u2013935","journal-title":"Neurochem Res"},{"issue":"Pt 8","key":"8445_CR182","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1093\/brain\/awq185","volume":"133","author":"C Brayne","year":"2010","unstructured":"Brayne C et al (2010) Education, the brain and dementia: neuroprotection or compensation? Brain 133(Pt 8):2210\u20132216","journal-title":"Brain"},{"issue":"4","key":"8445_CR183","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.arr.2004.05.001","volume":"3","author":"LJ Whalley","year":"2004","unstructured":"Whalley LJ et al (2004) Cognitive reserve and the neurobiology of cognitive aging. Ageing Res Rev 3(4):369\u2013382","journal-title":"Ageing Res Rev"},{"issue":"16","key":"8445_CR184","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1212\/WNL.0b013e3182515972","volume":"78","author":"BV Hooli","year":"2012","unstructured":"Hooli BV et al (2012) Role of common and rare APP DNA sequence variants in Alzheimer disease. Neurology 78(16):1250\u20131257","journal-title":"Neurology"},{"issue":"5580","key":"8445_CR185","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297(5580):353\u2013356","journal-title":"Science"},{"issue":"1","key":"8445_CR186","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-2001-3111","volume":"3","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe DJ (2001) Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimers Dis 3(1):75\u201380","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"8445_CR187","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1038\/emboj.2012.79","volume":"31","author":"L Chavez-Gutierrez","year":"2012","unstructured":"Chavez-Gutierrez L et al (2012) The mechanism of gamma-secretase dysfunction in familial Alzheimer disease. EMBO J 31(10):2261\u20132274","journal-title":"EMBO J"},{"issue":"4","key":"8445_CR188","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/(SICI)1096-8628(19990820)88:4<344::AID-AJMG10>3.0.CO;2-1","volume":"88","author":"DC Rubinsztein","year":"1999","unstructured":"Rubinsztein DC et al (1999) Apo E genotypes and risk of dementia in Down syndrome. Am J Med Genet 88(4):344\u2013347","journal-title":"Am J Med Genet"},{"issue":"2","key":"8445_CR189","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.neurobiolaging.2010.10.010","volume":"33","author":"D McNaughton","year":"2012","unstructured":"McNaughton D et al (2012) Duplication of amyloid precursor protein (APP), but not prion protein (PRNP) gene is a significant cause of early onset dementia in a large UK series. Neurobiol Aging 33(2):426, e13-21","journal-title":"Neurobiol Aging"},{"issue":"10","key":"8445_CR190","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1136\/jnnp.2006.113514","volume":"78","author":"A Rovelet-Lecrux","year":"2007","unstructured":"Rovelet-Lecrux A et al (2007) APP locus duplication in a Finnish family with dementia and intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 78(10):1158\u20131159","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 11","key":"8445_CR191","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1093\/brain\/awl237","volume":"129","author":"L Cabrejo","year":"2006","unstructured":"Cabrejo L et al (2006) Phenotype associated with APP duplication in five families. Brain 129(Pt 11):2966\u20132976","journal-title":"Brain"},{"issue":"48","key":"8445_CR192","doi-asserted-by":"crossref","first-page":"47370","DOI":"10.1074\/jbc.M308480200","volume":"278","author":"A Lleo","year":"2003","unstructured":"Lleo A et al (2003) Notch1 competes with the amyloid precursor protein for gamma-secretase and down-regulates presenilin-1 gene expression. J Biol Chem 278(48):47370\u201347375","journal-title":"J Biol Chem"},{"issue":"42","key":"8445_CR193","doi-asserted-by":"crossref","first-page":"41182","DOI":"10.1074\/jbc.M306403200","volume":"278","author":"A Kinoshita","year":"2003","unstructured":"Kinoshita A et al (2003) The intracellular domain of the low density lipoprotein receptor-related protein modulates transactivation mediated by amyloid precursor protein and Fe65. J Biol Chem 278(42):41182\u201341188","journal-title":"J Biol Chem"},{"issue":"47","key":"8445_CR194","doi-asserted-by":"crossref","first-page":"44754","DOI":"10.1074\/jbc.M206872200","volume":"277","author":"S Lammich","year":"2002","unstructured":"Lammich S et al (2002) Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Abeta-like peptide. J Biol Chem 277(47):44754\u201344759","journal-title":"J Biol Chem"},{"issue":"2","key":"8445_CR195","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1073\/pnas.0608332104","volume":"104","author":"J Shen","year":"2007","unstructured":"Shen J, Kelleher RJ 3rd (2007) The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism. Proc Natl Acad Sci U S A 104(2):403\u2013409","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8445_CR196","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-1-4614-0899-4_17","volume":"727","author":"K Roemer","year":"2012","unstructured":"Roemer K (2012) Notch and the p53 clan of transcription factors. Adv Exp Med Biol 727:223\u2013240","journal-title":"Adv Exp Med Biol"},{"issue":"10","key":"8445_CR197","doi-asserted-by":"crossref","first-page":"7102","DOI":"10.1073\/pnas.102192599","volume":"99","author":"R Roncarati","year":"2002","unstructured":"Roncarati R et al (2002) The gamma-secretase-generated intracellular domain of beta-amyloid precursor protein binds Numb and inhibits Notch signaling. Proc Natl Acad Sci U S A 99(10):7102\u20137107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"8445_CR198","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/jnr.20642","volume":"82","author":"A Fassa","year":"2005","unstructured":"Fassa A, Mehta P, Efthimiopoulos S (2005) Notch 1 interacts with the amyloid precursor protein in a Numb-independent manner. J Neurosci Res 82(2):214\u2013224","journal-title":"J Neurosci Res"},{"issue":"37","key":"8445_CR199","doi-asserted-by":"crossref","first-page":"25492","DOI":"10.1074\/jbc.M802072200","volume":"283","author":"GA Kyriazis","year":"2008","unstructured":"Kyriazis GA et al (2008) Numb endocytic adapter proteins regulate the transport and processing of the amyloid precursor protein in an isoform-dependent manner: implications for Alzheimer disease pathogenesis. J Biol Chem 283(37):25492\u201325502","journal-title":"J Biol Chem"},{"issue":"2","key":"8445_CR200","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1385\/JMN:17:2:171","volume":"17","author":"D Hartmann","year":"2001","unstructured":"Hartmann D et al (2001) Implication of APP secretases in notch signaling. J Mol Neurosci 17(2):171\u2013181","journal-title":"J Mol Neurosci"},{"issue":"4","key":"8445_CR201","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.bbrc.2009.10.093","volume":"390","author":"HN Woo","year":"2009","unstructured":"Woo HN et al (2009) Alzheimer's disease and Notch signaling. Biochem Biophys Res Commun 390(4):1093\u20131097","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"8445_CR202","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/(SICI)1097-4547(19980801)53:3<330::AID-JNR7>3.0.CO;2-B","volume":"53","author":"M Walton","year":"1998","unstructured":"Walton M et al (1998) Do c-Jun, c-Fos, and amyloid precursor protein play a role in neuronal death or survival? J Neurosci Res 53(3):330\u2013342","journal-title":"J Neurosci Res"},{"issue":"57","key":"8445_CR203","doi-asserted-by":"crossref","first-page":"7545","DOI":"10.1038\/sj.onc.1210064","volume":"25","author":"GV Ferrari De","year":"2006","unstructured":"De Ferrari GV, Moon RT (2006) The ups and downs of Wnt signaling in prevalent neurological disorders. Oncogene 25(57):7545\u20137553","journal-title":"Oncogene"},{"issue":"2","key":"8445_CR204","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.arr.2008.11.003","volume":"8","author":"RA Boonen","year":"2009","unstructured":"Boonen RA, van Tijn P, Zivkovic D (2009) Wnt signaling in Alzheimer's disease: up or down, that is the question. Ageing Res Rev 8(2):71\u201382","journal-title":"Ageing Res Rev"},{"issue":"4","key":"8445_CR205","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2174\/156720205774322557","volume":"2","author":"F Li","year":"2005","unstructured":"Li F, Chong ZZ, Maiese K (2005) Vital elements of the Wnt-Frizzled signaling pathway in the nervous system. Curr Neurovasc Res 2(4):331\u2013340","journal-title":"Curr Neurovasc Res"},{"issue":"2","key":"8445_CR206","first-page":"495","volume":"19","author":"ZZ Chong","year":"2004","unstructured":"Chong ZZ, Maiese K (2004) Targeting WNT, protein kinase B, and mitochondrial membrane integrity to foster cellular survival in the nervous system. Histol Histopathol 19(2):495\u2013504","journal-title":"Histol Histopathol"},{"issue":"5\u20136","key":"8445_CR207","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10540-005-2893-6","volume":"25","author":"A Caricasole","year":"2005","unstructured":"Caricasole A et al (2005) Two sides of the same coin: Wnt signaling in neurodegeneration and neuro-oncology. Biosci Rep 25(5\u20136):309\u2013327","journal-title":"Biosci Rep"},{"issue":"1","key":"8445_CR208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresrev.2004.11.005","volume":"49","author":"ZZ Chong","year":"2005","unstructured":"Chong ZZ, Li F, Maiese K (2005) Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease. Brain Res Brain Res Rev 49(1):1\u201321","journal-title":"Brain Res Brain Res Rev"},{"issue":"3","key":"8445_CR209","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pneurobio.2008.08.001","volume":"86","author":"EM Toledo","year":"2008","unstructured":"Toledo EM, Colombres M, Inestrosa NC (2008) Wnt signaling in neuroprotection and stem cell differentiation. Prog Neurobiol 86(3):281\u2013296","journal-title":"Prog Neurobiol"},{"issue":"3","key":"8445_CR210","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2174\/156720509788486608","volume":"6","author":"MI Behrens","year":"2009","unstructured":"Behrens MI, Lendon C, Roe CM (2009) A common biological mechanism in cancer and Alzheimer's disease? Curr Alzheimer Res 6(3):196\u2013204","journal-title":"Curr Alzheimer Res"},{"issue":"5","key":"8445_CR211","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0006-291X(02)02747-X","volume":"299","author":"JE Meredith Jr","year":"2002","unstructured":"Meredith JE Jr et al (2002) Gamma-secretase activity is not involved in presenilin-mediated regulation of beta-catenin. Biochem Biophys Res Commun 299(5):744\u2013750","journal-title":"Biochem Biophys Res Commun"},{"issue":"51","key":"8445_CR212","doi-asserted-by":"crossref","first-page":"48554","DOI":"10.1074\/jbc.M108332200","volume":"276","author":"R Killick","year":"2001","unstructured":"Killick R et al (2001) Presenilin 1 independently regulates beta-catenin stability and transcriptional activity. J Biol Chem 276(51):48554\u201348561","journal-title":"J Biol Chem"},{"issue":"14","key":"8445_CR213","doi-asserted-by":"crossref","first-page":"9359","DOI":"10.1074\/jbc.M707108200","volume":"283","author":"MH Magdesian","year":"2008","unstructured":"Magdesian MH et al (2008) Amyloid-beta binds to the extracellular cysteine-rich domain of Frizzled and inhibits Wnt\/beta-catenin signaling. J Biol Chem 283(14):9359\u20139368","journal-title":"J Biol Chem"},{"key":"8445_CR214","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1742-2094-4-29","volume":"4","author":"Y Chen","year":"2007","unstructured":"Chen Y, Bodles AM (2007) Amyloid precursor protein modulates beta-catenin degradation. J Neuroinflammation 4:29","journal-title":"J Neuroinflammation"},{"issue":"16","key":"8445_CR215","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1093\/hmg\/10.16.1665","volume":"10","author":"C Jonghe De","year":"2001","unstructured":"De Jonghe C et al (2001) Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect Abeta secretion and APP C-terminal fragment stability. Hum Mol Genet 10(16):1665\u20131671","journal-title":"Hum Mol Genet"},{"issue":"2","key":"8445_CR216","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1750-3639.2009.00321.x","volume":"20","author":"Z Helmond van","year":"2010","unstructured":"van Helmond Z et al (2010) Oligomeric Abeta in Alzheimer's disease: relationship to plaque and tangle pathology, APOE genotype and cerebral amyloid angiopathy. Brain Pathol 20(2):468\u2013480","journal-title":"Brain Pathol"},{"issue":"5","key":"8445_CR217","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1046\/j.1471-4159.1996.67051882.x","volume":"67","author":"K Furukawa","year":"1996","unstructured":"Furukawa K et al (1996) Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J Neurochem 67(5):1882\u20131896","journal-title":"J Neurochem"},{"issue":"1","key":"8445_CR218","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/neu.10203","volume":"55","author":"DH Lee","year":"2003","unstructured":"Lee DH, Wang HY (2003) Differential physiologic responses of alpha7 nicotinic acetylcholine receptors to beta-amyloid1-40 and beta-amyloid1-42. J Neurobiol 55(1):25\u201330","journal-title":"J Neurobiol"},{"issue":"3","key":"8445_CR219","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1046\/j.1471-4159.2003.02018.x","volume":"87","author":"K Zou","year":"2003","unstructured":"Zou K et al (2003) Amyloid beta-protein (Abeta)1-40 protects neurons from damage induced by Abeta1-42 in culture and in rat brain. J Neurochem 87(3):609\u2013619","journal-title":"J Neurochem"},{"issue":"2","key":"8445_CR220","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.nbd.2009.07.021","volume":"36","author":"GM Shankar","year":"2009","unstructured":"Shankar GM et al (2009) Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Abeta assembly forms throughout life. Neurobiol Dis 36(2):293\u2013302","journal-title":"Neurobiol Dis"},{"issue":"Suppl 1","key":"8445_CR221","first-page":"S111","volume":"33","author":"D Puzzo","year":"2013","unstructured":"Puzzo D, Arancio O (2013) Amyloid-beta peptide: Dr. Jekyll or Mr. Hyde? J Alzheimers Dis 33(Suppl 1):S111\u2013S120","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"8445_CR222","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/153331750602100213","volume":"21","author":"RJ Castellani","year":"2006","unstructured":"Castellani RJ et al (2006) Antioxidant protection and neurodegenerative disease: the role of amyloid-beta and tau. Am J Alzheimers Dis Other Demen 21(2):126\u2013130","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"12","key":"8445_CR223","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1080\/1071576021000049890","volume":"36","author":"DA Butterfield","year":"2002","unstructured":"Butterfield DA (2002) Amyloid beta-peptide (1\u201342)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic Res 36(12):1307\u20131313","journal-title":"Free Radic Res"},{"issue":"35","key":"8445_CR224","doi-asserted-by":"crossref","first-page":"32860","DOI":"10.1074\/jbc.M104135200","volume":"276","author":"WE Nostrand Van","year":"2001","unstructured":"Van Nostrand WE et al (2001) Pathogenic effects of D23N Iowa mutant amyloid beta-protein. J Biol Chem 276(35):32860\u201332866","journal-title":"J Biol Chem"},{"issue":"1","key":"8445_CR225","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0006-291X(02)00430-8","volume":"294","author":"K Murakami","year":"2002","unstructured":"Murakami K et al (2002) Synthesis, aggregation, neurotoxicity, and secondary structure of various A beta 1\u201342 mutants of familial Alzheimer's disease at positions 21\u201323. Biochem Biophys Res Commun 294(1):5\u201310","journal-title":"Biochem Biophys Res Commun"},{"issue":"9373","key":"8445_CR226","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/S0140-6736(03)13555-6","volume":"361","author":"S Tsubuki","year":"2003","unstructured":"Tsubuki S, Takaki Y, Saido TC (2003) Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Abeta to physiologically relevant proteolytic degradation. Lancet 361(9373):1957\u20131958","journal-title":"Lancet"},{"issue":"26","key":"8445_CR227","doi-asserted-by":"crossref","first-page":"23221","DOI":"10.1074\/jbc.M300276200","volume":"278","author":"L Morelli","year":"2003","unstructured":"Morelli L et al (2003) Differential degradation of amyloid beta genetic variants associated with hereditary dementia or stroke by insulin-degrading enzyme. J Biol Chem 278(26):23221\u201323226","journal-title":"J Biol Chem"},{"issue":"4","key":"8445_CR228","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1006\/nbdi.1998.0202","volume":"5","author":"C Jonghe De","year":"1998","unstructured":"De Jonghe C et al (1998) Flemish and Dutch mutations in amyloid beta precursor protein have different effects on amyloid beta secretion. Neurobiol Dis 5(4):281\u2013286","journal-title":"Neurobiol Dis"},{"issue":"2","key":"8445_CR229","first-page":"183","volume":"73","author":"SG Duinen van","year":"1995","unstructured":"van Duinen SG et al (1995) Cortical tissue of patients with hereditary cerebral hemorrhage with amyloidosis (Dutch) contains various extracellular matrix deposits. Lab Investig 73(2):183\u2013189","journal-title":"Lab Investig"},{"key":"8445_CR230","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1749-6632.2002.tb04824.x","volume":"977","author":"WE Nostrand Van","year":"2002","unstructured":"Van Nostrand WE et al (2002) Pathogenic effects of cerebral amyloid angiopathy mutations in the amyloid beta-protein precursor. Ann N Y Acad Sci 977:258\u2013265","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"8445_CR231","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3233\/JAD-2009-1042","volume":"17","author":"AJ Larner","year":"2009","unstructured":"Larner AJ, Doran M (2009) Genotype\u2013phenotype relationships of presenilin-1 mutations in Alzheimer's disease: an update. J Alzheimers Dis 17(2):259\u2013265","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"8445_CR232","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1471-4159.2005.03578.x","volume":"96","author":"M Bentahir","year":"2006","unstructured":"Bentahir M et al (2006) Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms. J Neurochem 96(3):732\u2013742","journal-title":"J Neurochem"},{"issue":"1","key":"8445_CR233","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1385\/NMM:2:1:29","volume":"2","author":"J Lee","year":"2002","unstructured":"Lee J, Chan SL, Mattson MP (2002) Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain. Neuromol Med 2(1):29\u201345","journal-title":"Neuromol Med"},{"issue":"29","key":"8445_CR234","doi-asserted-by":"crossref","first-page":"22350","DOI":"10.1074\/jbc.M110.116962","volume":"285","author":"EA Heilig","year":"2010","unstructured":"Heilig EA et al (2010) A presenilin-1 mutation identified in familial Alzheimer disease with cotton wool plaques causes a nearly complete loss of gamma-secretase activity. J Biol Chem 285(29):22350\u201322359","journal-title":"J Biol Chem"},{"key":"8445_CR235","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1326-3-20","volume":"3","author":"CL Maarouf","year":"2008","unstructured":"Maarouf CL et al (2008) Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutations. Mol Neurodegener 3:20","journal-title":"Mol Neurodegener"},{"issue":"1","key":"8445_CR236","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00401-009-0521-4","volume":"118","author":"C Shepherd","year":"2009","unstructured":"Shepherd C, McCann H, Halliday GM (2009) Variations in the neuropathology of familial Alzheimer's disease. Acta Neuropathol 118(1):37\u201352","journal-title":"Acta Neuropathol"},{"issue":"7409","key":"8445_CR237","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature11283","volume":"488","author":"T Jonsson","year":"2012","unstructured":"Jonsson T et al (2012) A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature 488(7409):96\u201399","journal-title":"Nature"},{"issue":"6","key":"8445_CR238","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1471-4159.2008.05715.x","volume":"107","author":"JD Lathia","year":"2008","unstructured":"Lathia JD, Mattson MP, Cheng A (2008) Notch: from neural development to neurological disorders. J Neurochem 107(6):1471\u20131481","journal-title":"J Neurochem"},{"issue":"4","key":"8445_CR239","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bbadis.2009.01.015","volume":"1792","author":"CJ Cairney","year":"2009","unstructured":"Cairney CJ et al (2009) A systems biology approach to Down syndrome: identification of Notch\/Wnt dysregulation in a model of stem cells aging. Biochim Biophys Acta 1792(4):353\u2013363","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"8445_CR240","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.atherosclerosis.2012.04.010","volume":"225","author":"ZJ Liu","year":"2012","unstructured":"Liu ZJ et al (2012) Notch activation induces endothelial cell senescence and pro-inflammatory response: implication of Notch signaling in atherosclerosis. Atherosclerosis 225(2):296\u2013303","journal-title":"Atherosclerosis"},{"issue":"1","key":"8445_CR241","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/156720509787313899","volume":"6","author":"M Stefani","year":"2009","unstructured":"Stefani M, Liguri G (2009) Cholesterol in Alzheimer's disease: unresolved questions. Curr Alzheimer Res 6(1):15\u201329","journal-title":"Curr Alzheimer Res"},{"issue":"3","key":"8445_CR242","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.pneurobio.2010.06.009","volume":"92","author":"E Polazzi","year":"2010","unstructured":"Polazzi E, Monti B (2010) Microglia and neuroprotection: from in vitro studies to therapeutic applications. Prog Neurobiol 92(3):293\u2013315","journal-title":"Prog Neurobiol"},{"issue":"6116","key":"8445_CR243","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1126\/science.1227901","volume":"339","author":"A Aguzzi","year":"2013","unstructured":"Aguzzi A, Barres BA, Bennett ML (2013) Microglia: scapegoat, saboteur, or something else? Science 339(6116):156\u2013161","journal-title":"Science"},{"issue":"2","key":"8445_CR244","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/1567202053586758","volume":"2","author":"PI Moreira","year":"2005","unstructured":"Moreira PI et al (2005) A second look into the oxidant mechanisms in Alzheimer's disease. Curr Neurovasc Res 2(2):179\u2013184","journal-title":"Curr Neurovasc Res"},{"issue":"3","key":"8445_CR245","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/1874609811003030158","volume":"3","author":"JA Driver","year":"2010","unstructured":"Driver JA, Lu KP (2010) Pin1: a new genetic link between Alzheimer's disease, cancer and aging. Curr Aging Sci 3(3):158\u2013165","journal-title":"Curr Aging Sci"},{"key":"8445_CR246","first-page":"911","volume":"374","author":"T Arendt","year":"1993","unstructured":"Arendt T (1993) Neuronal dedifferentiation and degeneration in Alzheimer's disease. Biol Chem 374:911\u2013912","journal-title":"Biol Chem"},{"key":"8445_CR247","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/0-387-29390-6_1","volume-title":"Cell cycle mechanisms in neuronal cell death","author":"T Arendt","year":"2005","unstructured":"Arendt T (2005) Cell cycle activation in neurons\u2014the final exit of brain morpho-dysregulation. In: Copani A, Nicoletti F (eds) Cell cycle mechanisms in neuronal cell death. Landes Bioscience and Kluwer Academic, Georgetown, pp 1\u201321"},{"issue":"6","key":"8445_CR248","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0197-4580(02)00036-2","volume":"23","author":"JP Blass","year":"2002","unstructured":"Blass JP (2002) Alzheimer's disease and Alzheimer's dementia: distinct but overlapping entities. Neurobiol Aging 23(6):1077\u20131084","journal-title":"Neurobiol Aging"},{"issue":"Pt 5","key":"8445_CR249","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/brain\/awq065","volume":"133","author":"JM Mc Donald","year":"2010","unstructured":"Mc Donald JM et al (2010) The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia. Brain 133(Pt 5):1328\u20131341","journal-title":"Brain"},{"issue":"1","key":"8445_CR250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0197-4580(02)00057-X","volume":"24","author":"SA Lyness","year":"2003","unstructured":"Lyness SA, Zarow C, Chui HC (2003) Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis. Neurobiol Aging 24(1):1\u201323","journal-title":"Neurobiol Aging"},{"issue":"1","key":"8445_CR251","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0197-4580(00)00211-6","volume":"22","author":"J Joseph","year":"2001","unstructured":"Joseph J et al (2001) Copernicus revisited: amyloid beta in Alzheimer's disease. Neurobiol Aging 22(1):131\u2013146","journal-title":"Neurobiol Aging"},{"issue":"1","key":"8445_CR252","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3121","volume":"13","author":"EB Lee","year":"2012","unstructured":"Lee EB, Lee VM, Trojanowski JQ (2012) Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat Rev Neurosci 13(1):38\u201350","journal-title":"Nat Rev Neurosci"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-013-8445-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-013-8445-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-013-8445-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T05:58:49Z","timestamp":1715147929000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-013-8445-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,3]]},"references-count":252,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["8445"],"URL":"https:\/\/doi.org\/10.1007\/s12035-013-8445-3","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,3]]}}}